Report cover image

Local Anesthesia Drugs Market

Publisher Coherent Market Insights
Published Mar 17, 2026
Length 151 Pages
SKU # CMI21064304

Description

Local anaesthesia involves numbing an area of the body using a type of medicine called a local anaesthetic. It is a type of pain control used during minor procedures to numb small area where the pain is likely to occur. The use of long-acting local anesthetic prolongs the anesthetic effect of regional anesthesia. Local anesthesia drugs can be used to treat painful conditions, prevent pain during a procedure or operation, or relieve pain after surgery. Local anesthetics are much safer to use, but have fewer side effects compared to general anesthetics.

Market Dynamics

Increasing use of local anesthesia drugs across the globe due to increase in number of surgeries and increasing use of local anesthetic for post-operative pain is expected to augment the growth of the global local anesthesia drugs market over the forecast period. For instance, according to the American Society of Plastic Surgeons, in 2020, over 6.8 million reconstructive procedures, 13.2 million cosmetic minimally invasive procedures, and around 2.3 million cosmetic surgical procedures were performed in the United States.

Moreover, in May 2021, the Food and Drug Administration (FDA) approved the first extended-release dual acting local anesthetic of bupivacaine and meloxicam for pain management.

Key features of the study
  • This report provides in-depth analysis of the global local anesthesia drugs market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2021–2028), considering 2020 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global local anesthesia drugs market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global local anesthesia drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global local anesthesia drugs market.
Market Segmentation
  • By Drug Type
  • Bupivacaine
  • Lidocaine
  • Benzocaine
  • Ropivacaine
  • Prilocaine
  • Chloroprocaine
  • Others
  • By Mode Of Administration
  • Injectable
  • Surface Anesthetic
  • By Regional Insights
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Key Players Insights
  • Septodont
  • Pfizer Inc.
  • Pacira BioSciences, Inc.
  • Braun Melsulgen AG
  • Glenmark Pharmaceutical Ltd.
  • Fresenius SE & Co. KgaA
  • Hikma Pharmaceuticals PLC
  • Teva Pharmaceutical Industries Ltd.

Table of Contents

151 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Nasal Drug Delivery Mode, By Drug Type
Market Nasal Drug Delivery Mode, By Mode of Administration
Market Nasal Drug Delivery Mode, By Geography
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Increase in number of surgeries worldwide
Side effects of anesthetic drugs
Growing use of local anesthetic drugs
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Local Anesthesia Drugs Market, By Drug Type, 2026 - 2033, (USD Bn)
Introduction
Market Share Analysis, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
Bupivacaine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Lidocaine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Benzocaine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Ropivacaine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Prilocaine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Chloroprocaine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Local Anesthesia Drugs Market, By Mode of Administration, 2026 - 2033, (USD Bn)
Introduction
Market Share Analysis, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
Injectable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Surface Anesthetic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Local Anesthesia Drugs Market, By Geography, 2026 - 2033, (USD Bn)
Introduction
Market Share Analysis, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
Countries
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
Countries
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
South Africa
North Africa
Central Africa
7. Competitive Landscape
Septodont
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pacira BioSciences, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Braun Melsulgen AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Glenmark Pharmaceutical Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Fresenius SE & Co. KgaA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Hikma Pharmaceuticals PLC
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Teva Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
8. Section
Research Methodology
About us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us